Expert Review of Molecular Diagnostics

Papers
(The TQCC of Expert Review of Molecular Diagnostics is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
LAMP Diagnostics at the Point-of-Care: Emerging Trends and Perspectives for the Developer Community115
Cystatin C as a biomarker of chronic kidney disease: latest developments62
The diagnostic methods in the COVID-19 pandemic, today and in the future40
Spectroscopy as a tool for detection and monitoring of Coronavirus (COVID-19)39
Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing antibodies37
The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis36
Advances in tests for colorectal cancer screening and diagnosis34
Developing multiplex ddPCR assays for SARS-CoV-2 detection based on probe mix and amplitude based multiplexing32
The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery31
Diagnosis for COVID-19: current status and future prospects29
Noninvasive detection of COPD and Lung Cancer through breath analysis using MOS Sensor array based e-nose29
Role of N6-methyladenosine modification in pathogenesis of ischemic stroke28
A CNN-aided method to predict glaucoma progression using DARC (Detection of Apoptosing Retinal Cells)28
Emerging circulating MiRNAs and LncRNAs in upper gastrointestinal cancers23
Critical insight into recombinase polymerase amplification technology23
Ultrasensitive circulating tumor DNA analysis enables precision medicine: experimental workflow considerations22
Enzymatic cross-linking of collagens in organ fibrosis – resolution and assessment22
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome22
Nanomaterial-based Optical and Electrochemical Biosensors for Amyloid beta and Tau: Potential for early diagnosis of Alzheimer’s Disease21
Aptamer-based sensing of breast cancer biomarkers: a comprehensive review of analytical figures of merit21
A review on current diagnostic techniques for COVID-1921
Point-by-Point Progress: Gonorrhea Point of Care Tests20
Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer20
Alpha-gal syndrome: challenges to understanding sensitization and clinical reactions to alpha-gal20
Common mutations of interest in the diagnosis of amyotrophic lateral sclerosis: how common are common mutations in ALS genes?20
Blood-based traumatic brain injury biomarkers – Clinical utilities and regulatory pathways in the United States, Europe and Canada20
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma20
Antimicrobial resistance prediction in Neisseria gonorrhoeae: current status and future prospects19
An overview of using fungal DNA for the diagnosis of invasive mycoses19
Metabolomics-based predictive biomarkers of radiation injury and countermeasure efficacy: current status and future perspectives19
Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes19
Concentration of cell-free DNA in different tumor types19
Circulating tumor cell clusters: Insights into tumour dissemination and metastasis18
Saliva as a sample type for SARS-CoV-2 detection: implementation successes and opportunities around the globe18
A review on human body fluids for the diagnosis of viral infections: scope for rapid detection of COVID-1918
Predictive biomarkers for systemic therapy of hepatocellular carcinoma17
Performance comparison of the Cobas® Liat® and Cepheid® GeneXpert® systems on SARS-CoV-2 detection in nasopharyngeal swab and posterior oropharyngeal saliva17
Diagnostic and Prognostic Significance of Dysregulated Expression of Circular RNAs in Osteosarcoma17
Emerging Role of Extracellular Vesicles in Biomarking the Gastrointestinal Diseases16
Circular RNAs: novel diagnostic and therapeutic targets for ischemic stroke16
dPCR application in liquid biopsies: divide and conquer16
RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?16
Point-of-care diagnostics for invasive aspergillosis: nearing the finish line16
Advances in gold nanoparticle technology as a tool for diagnostics and treatment of cancer16
New and developing diagnostic platforms for COVID-19: A systematic review15
Exploring the real-world effect of the SARS-CoV-2 pandemic on the molecular diagnostics for cancer patients and high-risk individuals15
Human tear fluid analysis for clinical applications: progress and prospects14
Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors – A systematic review14
Recent advances in the diagnosis monkeypox: implications for public health14
Clinical genomics and contextualizing genome variation in the diagnostic laboratory14
Recent advances in the diagnosis of COVID-19: a bird’s eye view14
Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling14
Mid-regional pro-adrenomedullin as a supplementary tool to clinical parameters in cases of suspicion of infection in the emergency department14
Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved : a systematic review14
Impact of non-antibiotic drugs on the human intestinal microbiome14
The importance of genomic analysis in cracking the coronavirus pandemic13
Advances in RT-LAMP for COVID-19 testing and diagnosis13
Improving laboratory diagnostics in myasthenia gravis13
Cervical cancer risk profiling: molecular biomarkers predicting the outcome of hrHPV infection13
Identification of the candidate lncRNA biomarkers for acute kidney injury: a systematic review and meta-analysis13
A profile of the binx health io® molecular point-of-care test for chlamydia and gonorrhea in women and men13
Future potential of metagenomics in microbiology laboratories13
Potential of CRISPR/Cas system in the diagnosis of COVID-19 infection13
Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer13
Noninvasive prenatal screening for fetal sex chromosome aneuploidies12
Clinical relevance ofliquid biopsyin breast cancer: update in 202012
Quantifying SARS-CoV-2 viral load: current status and future prospects12
Tumor treating fields: a comprehensive overview of the underlying molecular mechanism12
Liquid biopsy markers for stroke diagnosis12
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer12
Common markers of testicular Sertoli cells12
Quantitative versus qualitative estrogen and luteinizing hormone testing for personal fertility monitoring12
Improving genetic diagnostics of skeletal muscle channelopathies12
Applications of the CRISPR-Cas system for infectious disease diagnostics12
The diagnostic accuracy of seven commercial molecular in vitro SARS-CoV-2 detection tests: a rapid meta-analysis12
Optimizing testing regimes for the detection of COVID-19 in children and older adults12
Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis11
MicroRNA-217: a therapeutic and diagnostic tumor marker11
microRNAs as novel diagnostic biomarkers in endometriosis patients: a systematic review and meta-analysis11
Spatial profiling technologies and applications for brain cancers11
Point-of-care COVID-19 testing in the emergency department: current status and future prospects11
Viral metagenomic sequencing in the diagnosis of meningoencephalitis: a review of technical advances and diagnostic yield11
An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer11
Oral Potentially Malignant Disorders (OPMD): What is the clinical utility of dysplasia grade?10
Cell-free DNA as a potential biomarker for preeclampsia10
True or false: what are the factors that influence COVID-19 diagnosis by RT-qPCR?10
Construction of a 5-methylcytosine-Related Molecular Signature to Inform the Prognosis and Immunotherapy of Lung Squamous Cell Carcinoma10
Current and future strategies for diagnostic and management of obstructive sleep apnea10
Role of artificial intelligence and vibrational spectroscopy in cancer diagnostics10
Diagnostic accuracy of cerebrospinal fluid and serum-isolated extracellular vesicles for glioblastoma: a systematic review and meta-analysis10
Advances in the clinical use of collagen as biomarker of liver fibrosis10
Application of selected biosensor techniques in clinical diagnostics10
Assessing our approach to diagnosing Fibromyalgia10
Salivary biomarkers associated with obstructive sleep apnea: a systematic review10
Rapid metagenomics for diagnosis of bloodstream and respiratory tract nosocomial infections: current status and future prospects10
Utility of droplet digital PCR and NGS-based CNV clinical assays in hearing loss diagnostics: current status and future prospects9
ASSURED-SQVM diagnostics for COVID-19: addressing the why, when, where, who, what and how of testing9
The relationship between positivity for COVID-19 RT-PCR and symptoms, clinical findings, and mortality in Turkey9
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach9
Companion and complementary diagnostics: an important treatment decision tool in precision medicine9
Using lipocalin as a prognostic biomarker in acute kidney injury9
At-home coronavirus testing: the next game-changer?9
Highly sensitive droplet digital PCR-based diagnostics for the surveillance of malaria vector populations in low transmission and incipient resistance settings9
The clinical application of metagenomic next-generation sequencing for detecting pathogens in bronchoalveolar lavage fluid: case reports and literature review9
Research tests for the diagnosis of tuberculosis infection9
0.025358915328979